Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cerebrus Ltd.

Division of Ligand Pharmaceuticals Inc.
www.cerebrus.ltd.uk

Latest From Cerebrus Ltd.

Analysts Mixed As Australia’s CSL Moves To Settle U.S. Price Fixing Case

Australia’s CSL has probably made the right decision to settle a price-fixing lawsuit in the United States and thereby avoid a protracted legal battle that could have seen further substantial legal costs even if it eventually won. But the proposed settlement has some analysts concerned the legal basis for the lawsuit was thin as it stemmed from regulatory questions raised in a failed industry merger.

BioPharmaceutical Australia
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Ligand Pharmaceuticals Inc.
  • Senior Management
  • Paul Cowan, Fin. Dir.
    Colin T Dourish, PhD
  • Contact Info
  • Cerebrus Ltd.
    Phone: (44) 118 977 3133
    Oakdene Court, 613 Reading Rd.
    Winnersh, RG41 5UA
    UK
UsernamePublicRestriction

Register